IRIS
PETRACCA, MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.588
AS - Asia 3.572
EU - Europa 2.564
SA - Sud America 386
Continente sconosciuto - Info sul continente non disponibili 169
AF - Africa 107
OC - Oceania 11
Totale 10.397
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.342
SG - Singapore 1.459
RU - Federazione Russa 985
CN - Cina 738
IT - Italia 732
VN - Vietnam 633
BR - Brasile 298
DE - Germania 290
HK - Hong Kong 280
CA - Canada 143
FR - Francia 107
GB - Regno Unito 96
NL - Olanda 94
IN - India 81
JP - Giappone 72
BD - Bangladesh 61
FI - Finlandia 58
KR - Corea 54
UA - Ucraina 50
MX - Messico 35
ZA - Sudafrica 30
AR - Argentina 28
IE - Irlanda 28
CI - Costa d'Avorio 27
PH - Filippine 23
PL - Polonia 23
IQ - Iraq 22
ES - Italia 20
ID - Indonesia 19
TH - Thailandia 18
SE - Svezia 17
EC - Ecuador 16
TW - Taiwan 15
SA - Arabia Saudita 14
TR - Turchia 14
CO - Colombia 11
LT - Lituania 11
CR - Costa Rica 10
GT - Guatemala 10
PK - Pakistan 10
BE - Belgio 9
HN - Honduras 9
JM - Giamaica 9
PE - Perù 9
AT - Austria 8
MY - Malesia 8
JO - Giordania 7
MA - Marocco 7
TN - Tunisia 7
UZ - Uzbekistan 7
VE - Venezuela 7
AU - Australia 6
DO - Repubblica Dominicana 6
EG - Egitto 6
CL - Cile 5
CZ - Repubblica Ceca 5
NI - Nicaragua 5
NP - Nepal 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
AM - Armenia 4
BO - Bolivia 4
CH - Svizzera 4
DZ - Algeria 4
ET - Etiopia 4
IL - Israele 4
IR - Iran 4
KE - Kenya 4
NZ - Nuova Zelanda 4
SV - El Salvador 4
AL - Albania 3
CW - ???statistics.table.value.countryCode.CW??? 3
MN - Mongolia 3
NG - Nigeria 3
OM - Oman 3
PA - Panama 3
PT - Portogallo 3
PY - Paraguay 3
SC - Seychelles 3
SN - Senegal 3
BA - Bosnia-Erzegovina 2
EE - Estonia 2
GR - Grecia 2
HR - Croazia 2
KZ - Kazakistan 2
LB - Libano 2
LY - Libia 2
MD - Moldavia 2
MK - Macedonia 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
AD - Andorra 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BF - Burkina Faso 1
CG - Congo 1
CU - Cuba 1
Totale 10.214
Salva come PNG Salva come JPEG
Città #
Singapore 752
San Jose 671
Ashburn 438
Hong Kong 263
Hefei 250
Moscow 237
Council Bluffs 207
Beijing 194
Ho Chi Minh City 192
Santa Clara 176
Naples 156
Hanoi 142
Chandler 118
Los Angeles 111
Amsterdam 67
Tokyo 67
Lauterbourg 61
Dallas 55
Munich 55
Milan 47
New York 43
Seoul 43
Montreal 39
São Paulo 39
Buffalo 37
Napoli 35
Boston 33
Krefeld 33
Millbury 32
Phoenix 30
Orem 29
Chicago 27
Frankfurt am Main 27
Da Nang 26
Redondo Beach 26
Rome 26
Helsinki 25
The Dalles 25
Lawrence 24
Toronto 22
Atlanta 21
London 21
Des Moines 20
Haiphong 20
Seattle 20
Carrboro 19
Falkenstein 19
Chennai 18
Dublin 18
Denver 17
Johannesburg 16
Mexico City 16
Warsaw 16
Houston 15
Rottweil 15
Brooklyn 14
North Bergen 14
Poplar 13
Stockholm 13
Turku 13
Nanjing 12
Princeton 12
Wilmington 12
Baghdad 11
Biên Hòa 11
Ottawa 11
Mumbai 10
Pune 10
Tianjin 10
Washington 10
Boardman 9
Lappeenranta 9
San Francisco 9
Bangkok 8
Bari 8
Belo Horizonte 8
Brussels 8
Dong Ket 8
Manchester 8
Norwalk 8
Porto Alegre 8
Rio de Janeiro 8
Augusta 7
Bắc Giang 7
Can Tho 7
Charlotte 7
Guatemala City 7
Kyiv 7
Paris 7
Philadelphia 7
San José 7
Shanghai 7
Tashkent 7
Thái Bình 7
Vicenza 7
Amman 6
Ankara 6
Brasília 6
Florence 6
Hải Dương 6
Totale 5.547
Salva come PNG Salva come JPEG
Nome #
AQP4-MOG Double-Positive Neuromyelitis Optica Spectrum Disorder: Case Report with Central and Peripheral Nervous System Involvement and Review of Literature 292
Neurologia per le professioni sanitarie 284
MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis 196
GBA-Related Parkinson’s Disease:Dissection of Genotype–Phenotype Correlates in a LargeItalian Cohort 182
2D linear measures of ventricular enlargement may be relevant markers of brain atrophy and long-term disability progression in multiple sclerosis 181
Being highly sensitive person negatively impacts on cognitive and psychosocial fatigue in multiple sclerosis patients: A cross-sectional, monocenter study 175
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter Study 170
Prevalence and Incidence of Paramagnetic Rim Lesions in Multiple Sclerosis: A Systematic Review and Meta-Analysis 168
Validation of the Italian version of the Multiple Sclerosis Intimacy and Sexuality Questionnaire-19 166
Peripapillary Vessel Density as Early Biomarker in Multiple Sclerosis 164
Quality of Life Changes in Early-Onset Multiple Sclerosis: A 4-Year Follow-Up Study 163
Fertility, pregnancy and childbirth in women with multiple sclerosis: a population-based study from 2018 to 2020 159
Changes in lymphocytes, neutrophils and immunoglobulins in year-1 cladribine treatment in multiple sclerosis 158
Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis 157
The Italian Dystonia Registry: rationale, design and preliminary findings 157
ProspeCtive study to evaluate efficacy, safety and tOlerability of dietary supplemeNT of Curcumin (BCM95) in subjects with Active relapsing MultIple Sclerosis treated with subcutaNeous Interferon beta 1a 44 mcg TIW (CONTAIN): A randomized, controlled trial 157
Signs and symptoms of COVID-19 in patients with multiple sclerosis 156
Clinical correlates of R1 relaxometry and magnetic susceptibility changes in multiple sclerosis: a multi-parameter quantitative MRI study of brain iron and myelin 156
Cognitive trajectories in multiple sclerosis: a long-term follow-up study 155
The central vein sign helps in differentiating multiple sclerosis from its mimickers: lessons from Fabry disease 153
Neurofilament light chain and Alzheimer pathology biomarkers in elderly people with multiple sclerosis 153
Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex(®) 153
Effect of siponimod on lymphocyte subsets in active secondary progressive multiple sclerosis and clinical implications 152
Mental Health in Multiple Sclerosis During the COVID-19 Outbreak: A Delicate Balance between Fear of Contagion and Resilience 152
Clinical application of age-derived cut-offs for plasma neurofilament light chain in multiple sclerosis 151
Cerebellar lobule atrophy and disability in progressive MS 150
Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis 144
COVID-19 pandemic and mental distress in Multiple Sclerosis: implications for clinical management 143
Physical Exercise Moderates the Effects of Disability on Depression in People with Multiple Sclerosis during the COVID-19 Outbreak 143
Sexual dysfunction in multiple sclerosis: The impact of different MSISQ-19 cut-offs on prevalence and associated risk factors 141
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study 140
Mild or no COVID-19 symptoms in cladribine-treated multiple sclerosis: Two cases and implications for clinical practice 139
MR Imaging Signs of Gadolinium Retention Are Not Associated with Long-Term Motor and Cognitive Outcomes in Multiple Sclerosis 138
A retrospective exploratory analysis on cardiovascular risk and cognitive dysfunction in multiple sclerosis 138
Interplay Between Cognitive and Bowel/Bladder Function in Multiple Sclerosis 137
Identifying neuropsychological phenotypes in multiple sclerosis using latent profile analysis 136
Possible progressive multifocal leukoencephalopathy and active multiple sclerosis under dimethyl fumarate: the central role of MRI in informing therapeutic decisions 134
Idiopathic late-onset cerebellar ataxia with cerebellar atrophy in a patient diagnosed with Chiari I malformation: a case report. 134
Integration of the expanded disability status scale with ambulation, visual and cognitive tests 133
Ocrelizumab effect on humoral and cellular immunity in multiple sclerosis and its clinical correlates: a 3-year observational study 132
Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate. 132
The independent contribution of brain, spinal cord and gadolinium MRI in treatment decision in multiple sclerosis: A population-based retrospective study 131
Cerebellum and cognition in progressive MS patients: functional changes beyond atrophy? 130
Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg 130
Assessing brain involvement in Fabry disease with deep learning and the brain‐age paradigm 129
Efficacy of levetiracetam in hemifacial spasm: a case report. 127
Utilization of Ocrelizumab within Different Treatment Strategies for Multiple Sclerosis: A 5-Year Population-Based Study 125
Multiple sclerosis and systemic sclerosis: efficacy of interferon beta on skin lesions. 124
Tolosa-Hunt syndrome in a patient with autoimmune hemolytic anemia. 121
Sporadic Porphyria Cutanea Tarda in a Patient with Multiple Sclerosis Treated with Interferon Beta 1-a Therapy: A Case Report. 121
A Combined Radiomics and Machine Learning Approach to Overcome the Clinicoradiologic Paradox in Multiple Sclerosis 121
Association between CD20+ T lymphocytes and neuropsychological findings in multiple sclerosis 119
Spread of dystonia in patients with idiopathic adult-onset laryngeal dystonia 117
Quantitative MRI in Multiple Sclerosis: From Theory to Application 116
Sexual dysfunction in people with multiple sclerosis: The role of disease severity, illness perception, and depression 116
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania region 114
Walk your talk: Real-world adherence to guidelines on the use of MRI in multiple sclerosis 112
Switching to ozanimod as a strategy to adjust fingolimod-related lymphopenia 109
Persistence, adherence, healthcare resource utilization and costs for ocrelizumab in the real-world of the Campania Region of Italy 109
Emergency medical care for multiple sclerosis: A five-year population study in the Campania Region (South Italy) 107
Adult onset Rasmussen’s Encephalitis: a case report. 100
Low serum 25‑hydroxy-vitamin D levels are associated with cognitive impairment in multiple sclerosis 99
Google Maps Timeline: An open-access digital tool to monitor walking abilities in people with multiple sclerosis 98
Glossopharyngeal neuralgia as onset of multiple sclerosis. 97
Retinal and choriocapillary vascular changes in early stages of multiple sclerosis: A prospective study 96
Prevalence of autoimmine thyroiditis In an Italian multiple sclerosis cohort 89
Disability outcomes in early-stage African American and White people with multiple sclerosis 84
Cerebellum and neurodegenerative diseases: Beyond conventional magnetic resonance imaging 77
Machine learning classifier to identify clinical and radiological features relevant to disability progression in multiple sclerosis 75
Unraveling deep gray matter atrophy and iron and myelin changes in multiple sclerosis 72
The development of subcortical gray matter atrophy in multiple sclerosis: One size does not fit all 71
Neuroimaging correlates of cognitive dysfunction in adults with multiple sclerosis 70
Dysarthria assessment in multiple sclerosis patients 63
An MRI evaluation of grey matter damage in African Americans with MS 62
Predicting 10-Year Clinical Outcomes in MS with Radiomics-Based Machine Learning Models 55
Anti-EBV antibody reduction during ocrelizumab treatment is not associated with multiple sclerosis outcomes 51
Low serum 25‑hydroxy-vitamin D levels are associated with cognitive impairment in multiple sclerosis 47
Plasma neurofilament light chain to evaluate response during cladribine treatment in multiple sclerosis 41
Conventional MRI-Based Structural Disconnection and Morphometric Similarity Networks and Their Clinical Correlates in Multiple Sclerosis 40
Plasma Neurofilament Light Chain Is Associated with Cognitive Functions but Not Patient-Reported Outcomes in Multiple Sclerosis 38
A proof-of-concept study on the effectiveness of botulinum toxin on spasticity plus syndrome in multiple sclerosis 36
Clinical utility of the Lumipulse™ immunoassay for plasma neurofilament light chain in multiple sclerosis 36
Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study 35
null 33
Real-world analytical and clinical evaluation of the Siemens Atellica® immunoassay for plasma neurofilament light chain in multiple sclerosis 15
null 15
Totale 10.397
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.201
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.201
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022229 0 0 0 0 6 21 9 11 26 17 54 85
2022/2023562 42 49 11 9 39 64 151 26 61 57 36 17
2023/2024432 15 61 42 37 26 77 15 44 18 9 52 36
2024/20252.370 104 97 17 47 78 167 236 163 136 214 877 234
2025/20265.357 475 458 559 563 894 175 486 384 640 390 193 140
2026/20271.048 128 295 204 415 6 0 0 0 0 0 0 0
Totale 10.397